tiprankstipranks
Advertisement
Advertisement
Guangzhou Baiyunshan Pharma Sets Board Meeting to Review Q1 2026 Results
PremiumCompany AnnouncementsGuangzhou Baiyunshan Pharma Sets Board Meeting to Review Q1 2026 Results
1M ago
Guangzhou Baiyunshan Proposes 2025 Cash Dividend After Solid Earnings
Premium
Company Announcements
Guangzhou Baiyunshan Proposes 2025 Cash Dividend After Solid Earnings
2M ago
Guangzhou Baiyunshan Proposes Final 2025 Cash Dividend of RMB 0.45 Per Share
Premium
Company Announcements
Guangzhou Baiyunshan Proposes Final 2025 Cash Dividend of RMB 0.45 Per Share
2M ago
Baiyunshan Pharma Clears All Resolutions at Third Extraordinary General Meeting of 2025
PremiumCompany AnnouncementsBaiyunshan Pharma Clears All Resolutions at Third Extraordinary General Meeting of 2025
5M ago
Baiyunshan Pharma Subsidiary Finalises GP Guangkai Fund Deal, Liwan Fund Agreement Pending
Premium
Company Announcements
Baiyunshan Pharma Subsidiary Finalises GP Guangkai Fund Deal, Liwan Fund Agreement Pending
5M ago
Guangzhou Baiyunshan Subsidiary Secures Approval for New Rabies Vaccine
Premium
Company Announcements
Guangzhou Baiyunshan Subsidiary Secures Approval for New Rabies Vaccine
5M ago
Guangzhou Baiyunshan Plans Asset-Backed Securitization to Boost Liquidity
PremiumCompany AnnouncementsGuangzhou Baiyunshan Plans Asset-Backed Securitization to Boost Liquidity
6M ago
Guangzhou Baiyunshan’s GP Corp. Engages in Disclosable Transaction with Industrial Securities
Premium
Company Announcements
Guangzhou Baiyunshan’s GP Corp. Engages in Disclosable Transaction with Industrial Securities
6M ago
Guangzhou Baiyunshan Subsidiary Secures Land Reserve Compensation Agreement
Premium
Company Announcements
Guangzhou Baiyunshan Subsidiary Secures Land Reserve Compensation Agreement
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100